Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Press Release

Tallink becomes Hahn Air System’s second ferry partner Dreieich, 16th March 2017. Hahn Air Systems is pleased to announce that Tallink has become its second ferry partner to take advantage of its 5W-Rail&Shuttle product. By coming on board, Tallink’s passenger transport services will now be available under the 5W two-letter code in all major GDSs worldwide.This means that Tallink’s services can now be issued by over 100,000 travel agencies on the Hahn Air HR-169-document. It will also allow passengers to quickly and easily download their boarding passes at checkin.hahnair.com (

Press Release

Hahn Air Lines publishes flight schedule for summer 2017 Dreieich, 25th January 2017. Hahn Air Lines, the German scheduled and business jet charter airline based at Düsseldorf and Frankfurt Egelsbach, recently announced its flight schedule for the 2017 summer season. The carrier will continue its bi-weekly service between Düsseldorf (DUS) and Luxembourg (LUX) on Mondays and Fridays which it has been offering since 2010.  “We are very pleased that our flights will continue to be operated in code-share with our longstanding partner Luxair (LG)”, says Daniel Rudas, General

2X Oncology Inc. – a private spinout of Oncology Venture – to Present at Jefferies Global Healthcare Conference

Hoersholm, Denmark; May 31st, 2017 – Oncology Venture Sweden AB (OV:ST) announces that its spinout 2X Oncology, Inc., a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, will present at the upcoming Jefferies Global Healthcare Conference in New York City. The presentation will be given by George O. Elston, chief executive officer of 2X Oncology, on Friday, June 9 at 10:00 am EDT. The presentation will be webcast live and archived for 90 days on the 2X Oncology website, 2xoncology.com , under the ‘News (

Senzime initiates clinical study with CliniSenz System

Uppsala, May 31, 2017. Senzime AB (publ) initiates a clinical trial with CliniSenz for monitoring of tissue lactate levels after surgery in patients with esophageal cancer, a disease that affects approximately 500,000 patients worldwide annually. The current treatment is mostly surgical with risk of multiple operations and increased mortality. With CliniSenz System, it is possible to monitor the healing process after surgery and detect complications at an early stage. The study has been approved by the Ethics Committee and is expected to start in the beginning of June 2017.Senzime has

Novacura in new collaboration with Elinorr

Novacura will supply a growing number of new system solutions in Norrland, Sweden, as a result of the signing of a new framework agreement. Elinorr, the financial association that includes eighteen electricity companies in the region, signed the agreement with Novacura in November 2016. It is valid for four years with an option for extension. Elinorr has responsibility for 294,000 customers and 2,500 million grid networks in southern and central Norrland. Around 550 personnel are employed at the eighteen companies under its wing. The Novacura solution that Elinorr has chosen to

Press Release

Volaris initiates distribution via Hahn Air Systems’ H1 code Dreieich, 5th January 2017. Mexican low-cost-carrier Volaris signed an agreement with Hahn Air Systems, the global consolidation service connecting air, rail and shuttle partners to all major Global Distribution Systems (GDSs). Without having a direct GDS interface of its own, Volaris will now be able to make its flights available to travel agencies worldwide, under the reservation code H1, through the GDSs Amadeus, Sabre and Galileo, and Worldspan coming later in 2017. With the H1-Air product, Hahn Air Systems

Press Release

Ernest distributes globally under Hahn Air Systems’ H1 code Dreieich, 16th January 2017. Hahn Air Systems and Ernest signed an agreement which increases the virtual carrier’s visibility by allowing it to be distributed under the H1 code in all major GDSs worldwide. Globally, travel agencies can issue Ernest on the insolvency-safe Hahn Air ticket using the standard GDS ticketing process. Ernest is an Italian virtual airline based in Milan, with its flights operated by Mistral Air (M4). Using 737-400 and ATR 72 aircrafts, Ernest serves over 15 Italian cities including Ancona (AOI)

Press Release

Hahn Air appoints Dennis Huk as new Head of Global Account Management Dreieich, 14th March 2017. Hahn Air, the German scheduled airline and leading distribution service provider for other airlines, announced the appointment of Dennis Huk as Head of Global Account Management. Together with Robert Jason Heerenveen, who has occupied the position since February 2015, Dennis Huk will lead a team of more than 20 Directors Global Account Management and Service Partners around the globe who are responsible for executing sales and marketing activities as well as trainings and product

Axfood acquires Middagsfrid

Axfood is acquiring, through its subsidiary Matse Holding AB, 100% of the ownership of Middagsfrid. “Through this acquisition we will strengthen and further broaden our customer offering,” says Klas Balkow, President and CEO of Axfood.  Middagsfrid, established in 2007, was first in the world to offer ready-packed grocery bags with predefined recipes directly home to customers’ doors. The company today has some 20 employees and delivers groceries home to customers at some 300 locations throughout Sweden. Sales in 2016 amounted to approximately SEK 75 m. The company has offices and test

Revenio Group Corporation: Managers' transactions

Revenio GroupCorporation,Managers'transactions,May 31, 2017 at15:30Revenio GroupCorporation:Managers'transactionsPerson subjectto thenotificationrequirementName: Karvo, TomiPosition: Other senior manager InitialNotificationReference 743700I27E0FWSXLKK04_20170524134642_2number: IssuerName: Revenio Group OyjLEI: 743700I27E0FWSXLKK04 TransactiondetailsTransaction 2017-05-30date:Nature of the Acceptance of a Stock Optiontransaction:Furtherdetails: Linked to

Revenio Group Corporation: Managers' transactions

Revenio GroupCorporation,Managers'transactions,May 31, 2017 at15:30Revenio GroupCorporation:Managers'transactionsPerson subjectto thenotificationrequirementName: Hildén, TimoPosition: Chief Executive Officer InitialNotificationReference 743700I27E0FWSXLKK04_20170524134544_2number: IssuerName: Revenio Group OyjLEI: 743700I27E0FWSXLKK04 TransactiondetailsTransaction 2017-05-30date:Nature of the Acceptance of a Stock Optiontransaction:Furtherdetails: Linked

Revenio Group Corporation: Managers' transactions

Revenio GroupCorporation,Managers'transactions,May 31, 2017 at15:30Revenio GroupCorporation:Managers'transactionsPerson subjectto thenotificationrequirementName: Kukkonen, AriPosition: Other senior manager InitialNotificationReference 743700I27E0FWSXLKK04_20170524134242_2number: IssuerName: Revenio Group OyjLEI: 743700I27E0FWSXLKK04 TransactiondetailsTransaction 2017-05-30date:Nature of the Acceptance of a Stock Optiontransaction:Furtherdetails: Linked to

Revenio Group Corporation: Managers' transactions

Revenio Group Corporation, Managers' transactions, May 31, 2017 at 15:30 Revenio Group Corporation: Managers' transactions Person subjectto thenotificationrequirementName: Pulkkinen, RobinPosition: Chief Financial Officer InitialNotificationReference 743700I27E0FWSXLKK04_20170524134755_2number: IssuerName: Revenio Group OyjLEI: 743700I27E0FWSXLKK04 TransactiondetailsTransaction 2017-05-30date:Nature of the Acceptance of a Stock Optiontransaction:Furtherdetails: Linked

Revenio Group Corporation: Managers' transactions

Revenio GroupCorporation,Managers'transactions,May 31, 2017 at15:30Revenio GroupCorporation:Managers'transactionsPerson subjectto thenotificationrequirementName: Isomäki, AriPosition: Other senior manager InitialNotificationReference 743700I27E0FWSXLKK04_20170524133914_2number: IssuerName: Revenio Group OyjLEI: 743700I27E0FWSXLKK04 TransactiondetailsTransaction 2017-05-230date:Nature of the Acceptance of a Stock Optiontransaction:Furtherdetails: Linked to

New initiative from HDK: OPEN WEEK - Gothenburg Design Festival, 20–26 November 2017

What does it mean to be an open university? During the new initiative OPEN WEEK - Gothenburg Design Festival, HDK, in collaboration with partners, will test new formats for displaying learning in design and crafts. The ambition is to engage in a critical discussion in order to provide new insights that can further develop learning, research and future directions for design and crafts practice.Onkar Kular is professor in design interventions at HDK, since autumn 2015. The assignment as curator / artistic lead for the Göteborg Design Festival fits well with his previous experiences at the

Clas Ohlson’s new bags made of sugar cane

Starting 1 June 2017 Clas Ohlson is exchanging all plastic carrier bags in Swedish stores to new bags made of sugar cane. The exchange continues in Clas Ohlson’s other markets in August this year. Several other changes are being made to decrease littering and to save the Earth’s resources.As a further step, Clas Ohlson ceases to offer the small complimentary bag, and improves the quality of the remaining bags to enable reuse of bags. The company replaces the largest carrier bag with a new, more durable bag in nice design suitable for reusing. The price of the bags is being increased in

Enea launches high performance, lightweight virtualization platform for Customer Premise Equipment (CPE)

Enea® NFV Access is optimized for minimal footprint, high throughput, and optimized virtualization and container performanceSTOCKHOLM, Sweden, May 31, 2017 – Enea® (NASDAQ OMX Nordic:ENEA) today announced Enea® NFV Access – a lightweight virtualization platform tailored for customer premise deployment at the network edge. Enea NFV Access is optimized for minimal footprint, and high throughput for virtual network functions (VNFs) running in KVM and Docker containers. Enea NFV Access supports both ARM and x86 white boxes enabling operators and service providers to meet a wider range of price

CFO leaves Actic Group

Gustav Vadenbring, has decided to leave after five years as CFO for Actic Group. He remains in his current position as CFO until leaving the company during the autumn 2017. A process for recruiting his successor begins immediately."Gustav Vadenbring took up his position as CFO shortly after our main owner IK lnvest acquired Actic in 2012. For five years, he has played a central role and has been instrumental in developing the company to where we are today. He has also responded to significant effort in connection with the stock exchange listing, a work that has also meant a high workload

Sobi™ discloses payments to the healthcare professionals and healthcare organisations to increase transparency

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces that the company has made all payments and transfers of value to healthcare professionals and organisations from 2016 publicly available*, including sponsorships to attend meetings, grants and donations, speaker fees, consultancy and advisory boards in accordance with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code. The information is made available on Sobi´s corporate web site , starting 31

Ownership arrangement in Biohit Oyj’s Chinese Joint Venture completed

Biohit Oyj Inside information, 31[st] May, 2017 at 2 pm local time (EEST) On the 2nd of January 2017 Biohit Oyj made an announcement regarding the share capital reduction of its joint venture Biohit HealthCare (Hefei) Co. Ltd thereby assigning ownership in the company. The transaction has received the necessary approval from the authority and the company’s share capital has been reduced by an amount equal to Biohit Oyj’s shareholding. Resulting from the transaction, a profit of approximately EUR 8.5 million will be booked in the first half of Biohit Oyj’s operating result impairing

BIMobject AB: Solar increases equity interest in BIMobject

BIMobject AB ("BIMobject") hereby releases a disclosure notice stating that Solar A/S ("Solar"), the biggest shareholder in the company, has increased its equity interest in BIMobject today to equal more than 20 per cent. Solar previously owned 10,338,566 shares in BIMobject, corresponding to 19.99 per cent of the voting shares and capital of BIMobject. After having acquired an additional 11,434 shares on the stock market, Solar now owns a total of 10,350,000 shares, equalling 20.01% per cent of the voting shares and capital of BIMobject. About Solar A/SSolar Group is a leading

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During May 2017, 29,280 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,778,370. The total number of registered shares in the company amounts to 419,903,072, of which 19,763,922 are Series A shares, and 400,139,150 are Series B shares.

Oncology Venture – Successful US patent strategy – Irofulven Claims Accepted - English version of Swedish press release published Monday 29th May 2017

Hoersholm; May 31th, 2017 – Oncology Venture Sweden AB (OV:ST) today announced that Oncology Venture was informed by the US Patent Office that it will allow the claims in a patent application for a response predictor (DRP™) for Oncology Ventures anticancer drug Irofulven. A patent will be issued by the US Patent Office in the near future. The Orange Book allows listing of biomarker patents that are required for the screening of patients for treatment with a specific drug. After that, a generic drug cannot be filed to replace Irofulven for as long as the biomarker patent is valid."This is

There are no items matching the current filter
There are no more items matching the current filter
Back to top